Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage

Cytology for PD-L1 testing: A systematic review

(2020) John R. Gosney et al.   LUNG CANCER

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC

(2020) Hidenobu Ishii et al.   Thoracic Cancer

Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC

(2020) Caroline Volz et al.   Cell Reports

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

(2020) Giovanni Rossi et al.   Cancers

Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial

(2020) Célia Dupain et al.   Molecular Oncology

Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

(2020) Anna Passarelli et al.   Frontiers in Immunology

Toward Systems Biomarkers of Response to Immune Checkpoint Blockers

(2020) Óscar Lapuente-Santana et al.   Frontiers in Oncology

Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer

(2020) Sinchita Roy-Chowdhuri   Translational Lung Cancer Research

Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches

(2020) Elizabeth A. Thompson et al.   Annual Review of Medicine

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

(2019) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non‐Small Cell Lung Cancer: A Review

(2019) Nagla Abdel Karim et al.   ONCOLOGIST

Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

(2019) Kathryn C. Arbour et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment

(2019) Shi Yong Neo et al.   JOURNAL OF CLINICAL INVESTIGATION

Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations

(2018) Bryce Noll et al.   CANCER CYTOPATHOLOGY

Rapidly changing treatment algorithms for metastatic nonsquamous non-small-cell lung cancer

(2018) B. Melosky   Current Oncology

PD-L1 immunoexpression in matched biopsy and liquid based cytology samples of advanced stage non-small cell lung carcinomas

(2018) Deepali Jain et al.   CYTOPATHOLOGY

A fine needle aspiration-based protein signature discriminates benign from malignant breast lesions

(2018) Bo Franzén et al.   Molecular Oncology

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

(2018) Leena Gandhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Developing a Roadmap for Interventional Oncology

(2018) Stefan O. Schoenberg et al.   ONCOLOGIST

Targeting adenosine for cancer immunotherapy

(2018) Robert D. Leone et al.   Journal for ImmunoTherapy of Cancer

Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer

(2018) Arsela Prelaj et al.   EUROPEAN JOURNAL OF CANCER

Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer

(2018) Bo Franzén et al.   Molecular Oncology

Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx

(2017) Birgit G. Skov et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer

(2016) Katherine R. Amato et al.   CANCER RESEARCH

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

(2016) P.-L. Chen et al.   Cancer Discovery

Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer

(2016) Ghazal Efazat et al.   Oncotarget

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC

(2014) Katherine R. Amato et al.   JOURNAL OF CLINICAL INVESTIGATION

Therapeutic targeting of EPH receptors and their ligands

(2013) Andrew W. Boyd et al.   NATURE REVIEWS DRUG DISCOVERY

Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules

(2010) A. Fassina et al.   CYTOPATHOLOGY

EphA2 in the Early Pathogenesis and Progression of Non-Small Cell Lung Cancer

(2009) J. M. Brannan et al.   Cancer Prevention Research

Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non-Small Cell Lung Cancer

(2009) J. M. Brannan et al.   CLINICAL CANCER RESEARCH